Secondly, azithromycin suppresses conjunctival inflammation, which may block the activation of nuclear factor-kappa B (NF-κB), leading to decreased inflammatory cytokine levels such as interleukin-6 and -8 to improve dry eye symptoms [33]. The gene discussed is IL6; the disease is dry eye syndrome.